GJIC
BHC icon

Gamble Jones Investment Counsel’s Bausch Health BHC Stock Holding History

Gamble Jones Investment Counsel’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-92,319
Closed -$9.38M – 203
2015
Q4 		$9.38M Sell
92,319
-7,268
-7% -$817K 1.04% 20
2015
Q3 		$17.8M Buy
99,587
+10,352
+12% +$2.41M 2.04% 6
2015
Q2 		$19.8M Buy
89,235
+10,282
+13% +$2.28M 2.06% 6
2015
Q1 		$15.7M Buy
78,953
+10,287
+15% +$1.82M 1.63% 10
2014
Q4 		$9.83M Buy
68,666
+4,556
+7% +$613K 1.02% 18
2014
Q3 		$8.41M Buy
64,110
+4,269
+7% +$509K 0.93% 22
2014
Q2 		$7.55M Buy
59,841
+5,716
+11% +$729K 0.84% 25
2014
Q1 		$7.13M Buy
54,125
+12,910
+31% +$1.77M 0.83% 25
2013
Q4 		$4.84M Buy
41,215
+6,723
+19% +$737K 0.57% 34
2013
Q3 		$3.6M Buy
34,492
+5,889
+21% +$574K 0.46% 41
2013
Q2 		$2.46M Buy
+28,603
New +$2.25M 0.32% 53

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Gamble Jones Investment Counsel's BHC Position: Q1 2016 in Review

Gamble Jones Investment Counsel sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 92,319 shares — an estimated $9.38M sold.

Gamble Jones Investment Counsel first reported a position in BHC in Q2 2013 and held it in 11 quarters. The position peaked at $19.8M in Q2 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

  • Gamble Jones Investment Counsel reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
  • Gamble Jones Investment Counsel sold 92,319 Bausch Health shares in Q1 2016, an estimated $9.38M.
  • Gamble Jones Investment Counsel first reported a position in Bausch Health in Q2 2013 and held it in 11 quarters.
  • Gamble Jones Investment Counsel's Bausch Health position peaked at $19.8M in Q2 2015.
  • 389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Gamble Jones Investment Counsel's 13F filing for Q1 2016, filed 2 May 2016.